Myrcludex B

Business Offer

United States

Myrcludex B is an experimental drug for the treatment of hepatitis B and D. The hepatitis B virus uses its surface lipopeptide pre-S1 for docking to mature liver cells via their sodium/bile acid cotransporter (NTCP) and subsequently entering the cells. Myrcludex B is a synthetic N-acylated pre-S1 that can also dock to NTCP, blocking the virus's entry mechanism. For more information, please visit the website: https://www.creative-peptides.com/product/myrcludex-b-item-10-101-139-34585.html

[RequestAdvantages]

[RequestComments]

741

Cathy Miller